Paclitaxel Is Safe and Effective in the Treatment of Advanced AIDS-Related Kaposi's Sarcoma

The Statistical Analysis of Failure Time Data.

1981 • 10,224 citations

Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms

1989 • 1,111 citations

Taxol: A Novel Investigational Antimicrotubule Agent

1990 • 1,084 citations

THE IMPACT OF NATIONAL CANCER ACT

1991 • 809 citations

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

1991 • 730 citations

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1998 • 625 citations

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1992 • 619 citations

Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.

1997 • 525 citations

Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.

1989 • 459 citations

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.

1996 • 431 citations

Taxol: Mechanisms of Action and Resistancea

1986 • 415 citations

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

1998 • 354 citations

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.

1995 • 243 citations

Treatment of HIV-associated Kaposi's sarcoma with paclitaxel

1995 • 210 citations

Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial

1991 • 198 citations

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.

1984 • 182 citations

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.

1998 • 175 citations

Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.

1997 • 170 citations

Vinblastine Therapy for Kaposi's Sarcoma in the Acquired Immunodeficiency Syndrome

1985 • 149 citations

Treatment of Kaposi's Sarcoma and Thrombocytopenia with Vincristine in Patients with the Acquired Immunodeficiency Syndrome

1985 • 140 citations

Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor.

1997 • 126 citations

Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma.

1989 • 73 citations

Combination chemotherapy of disseminated kaposi's sarcoma in patients with the acquired immune deficiency syndrome

1987 • 71 citations

Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy.

1997 • 53 citations

Taxol-based combination chemotherapy and other in vivo preclinical antitumor studies.

1993 • 31 citations